DM1
Clinical trials for DM1 explained in plain language.
Never miss a new study
Get alerted when new DM1 trials appear
Sign up with your email to follow new studies for DM1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial hopes to ease muscle stiffness in rare disease
Disease control Recruiting nowThis study tests a new medicine, DYNE-101, for adults with myotonic dystrophy type 1, a condition that causes muscle weakness and stiffness. About 150 people will receive either the drug or a placebo for 48 weeks. The goal is to see if the drug improves muscle function, like stan…
Matched conditions: DM1
Phase: PHASE3 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
No travel needed: new study aims to unravel mysteries of myotonic dystrophy
Knowledge-focused Recruiting nowThis study looks at why myotonic dystrophy type 1 affects people so differently—some have mild symptoms, others severe. Researchers will measure muscle strength, memory, and activity using tools mailed to your home, and analyze your DNA from a blood sample. The goal is to better …
Matched conditions: DM1
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated May 26, 2026 08:13 UTC
-
Spain launches massive DM1 registry to unlock disease secrets
Knowledge-focused Recruiting nowThis study aims to create a comprehensive national registry for Myotonic Dystrophy Type 1 (DM1) in Spain, collecting clinical, genetic, and protein data from 3,000 participants. By gathering detailed information, researchers hope to better understand the disease and identify peop…
Matched conditions: DM1
Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC